Tumor suppressor XAF1 induces apoptosis, inhibits angiogenesis and inhibits tumor growth in hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Tumor suppressor XAF1 induces apoptosis, inhibits angiogenesis and inhibits tumor growth in hepatocellular carcinoma.

Tumor suppressor XAF1 induces apoptosis, inhibits angiogenesis and inhibits tumor growth in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34221867

about

Methylated circulating tumor DNA in blood: power in cancer prognosis and response Mouse models of liver cancer: Progress and recommendations Heterogeneous nuclear ribonucleoprotein K is associated with poor prognosis and regulates proliferation and apoptosis in bladder cancer.Hydrogen sulfide acts as a double-edged sword in human hepatocellular carcinoma cells through EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways Zika Virus Persistently Infects and Is Basolaterally Released from Primary Human Brain Microvascular Endothelial Cells.JAK2 inhibitor TG101348 overcomes erlotinib-resistance in non-small cell lung carcinoma cells with mutated EGF receptor.Epigenetic silencing of the XAF1 gene is mediated by the loss of CTCF binding.Cancer-associated oxidoreductase ERO1-α drives the production of VEGF via oxidative protein folding and regulating the mRNA level.Targeting tumor vasculature through oncolytic virotherapy: recent advances.Human basonuclin 2 up-regulates a cascade set of interferon-stimulated genes with anti-cancerous properties in a lung cancer model.Epigenetic silencing of XAF1 in high-grade gliomas is associated with IDH1 status and improved clinical outcome.Prognostic value of a 25-gene assay in patients with gastric cancer after curative resection.Stimulation of the hypoxia pathway modulates chemotherapy resistance in Hodgkin's lymphoma cells.Systemic genome screening identifies the outcome associated focal loss of long noncoding RNA PRAL in hepatocellular carcinoma.Decitabine-Vorinostat combination treatment in acute myeloid leukemia activates pathways with potential for novel triple therapy.Identification of XAF1-MT2A mutual antagonism as a molecular switch in cell-fate decisions under stressful conditions.Anti‑angiogenesis gene therapy for hepatocellular carcinoma via systemic injection of mesenchymal stem cells engineered to secrete soluble Flt‑1.Inhibitors of apoptosis: clinical implications in cancer.A novel fiber chimeric conditionally replicative adenovirus-Ad5/F35 for tumor therapy.XAF1 forms a positive feedback loop with IRF-1 to drive apoptotic stress response and suppress tumorigenesis

P2860

Q26772077-32CD9D86-09CB-4CC9-9F47-3D99561986F0 Q26799788-3E038245-557D-4A4F-B740-B59284798444 Q33844635-4B35E7F2-8A70-49B4-94B3-6EE271F23991 Q33895006-2983800F-4410-4939-AB6E-28099306504F Q33911252-1E55D776-6D51-4064-B3EC-4CE7615D2967 Q35987345-B305A227-7A6A-4E59-8A0F-DAB33D144D8E Q36129174-CB9C61BE-0BBA-4EF2-B466-D47152C822A5 Q36964306-2CA78106-5F86-40FA-A42B-DA09B67F8D75 Q37031932-2FE1051F-27E3-46ED-9C14-DE74E2804DC0 Q37628005-819E3E52-7F0A-4B35-BEDF-550142C26876 Q37716498-48C30F41-714F-42C4-9392-7A77FF3907BF Q38633179-4D66BC01-9CE8-424A-B6B1-D41C337BE6EB Q38807893-D9B53154-8050-4821-9F08-1841BEEE0BF2 Q39629883-7BBF98A0-D70A-4AB2-833E-7AFDFD368910 Q41612823-3A34E314-66DE-4831-9727-FF8754F730BF Q44871312-FACE7E44-0337-483A-96E1-984038367312 Q45871288-8551A296-2000-4B05-AEA8-54DA93412C21 Q47607136-63B8914F-A9A5-4EE3-BB13-40B0FBC780AA Q49963933-37E39613-85EF-4F66-9D52-506DE92D91BD Q58374432-7B3CF971-CD0F-4749-8119-1277AF3156FE

P2860

Tumor suppressor XAF1 induces apoptosis, inhibits angiogenesis and inhibits tumor growth in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34221867

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Tumor suppressor XAF1 induces ...... h in hepatocellular carcinoma.

@ast

Tumor suppressor XAF1 induces ...... h in hepatocellular carcinoma.

@en

Tumor suppressor XAF1 induces ...... h in hepatocellular carcinoma.

@nl

type

label

Tumor suppressor XAF1 induces ...... h in hepatocellular carcinoma.

@ast

Tumor suppressor XAF1 induces ...... h in hepatocellular carcinoma.

@en

Tumor suppressor XAF1 induces ...... h in hepatocellular carcinoma.

@nl

prefLabel

Tumor suppressor XAF1 induces ...... h in hepatocellular carcinoma.

@ast

Tumor suppressor XAF1 induces ...... h in hepatocellular carcinoma.

@en

Tumor suppressor XAF1 induces ...... h in hepatocellular carcinoma.

@nl

P1433

Q34221867-A2665472-51B8-41BC-9555-C32369EAE761

P1476

Q34221867-7DD5EB90-125B-459A-AD5B-8340F1A67CD6

P2093

Q34221867-2D013EFC-6BB7-45DE-ABD4-DDA99D145C78

Q34221867-300EFCBD-82C2-4118-B5A3-CE9C47662571

Q34221867-3205304E-A4B5-48E9-997A-86575FE58337

Q34221867-3E4A2AC3-6F3C-4577-ACE4-30ADBCD5611F

Q34221867-75132A39-910A-4D4B-A329-13A7291E6969

Q34221867-93175C74-21FE-48F3-8C36-DA54AC26C842

Q34221867-B56F235C-1D5C-4F17-B67A-2415AE3FB19E

Q34221867-CDF62368-CFBB-4A6D-8B97-8C893EFFCAE8

Q34221867-D1D458E8-1896-4674-A61E-A4393D0AA9BC

Q34221867-DE706E40-F419-4C17-8070-E75F1B209EB7

P2860

Q34221867-0465A3CB-E68E-4A5C-8C3B-E79811CA30B2

Q34221867-07320165-B666-41CB-9102-6804BA5468B9

Q34221867-13DBA119-F7FF-43BE-A3CB-053C6087C05E

Q34221867-1491CB37-2B51-4D2A-92BA-216D738D33C1

Q34221867-18C5B0C0-7B75-49F4-853D-3429C0CB9E32

Q34221867-1B493744-ECDF-4833-A50E-2676F9A86DA5

Q34221867-2279B2EF-E363-4A7B-8EE1-23CFF9C38E86

Q34221867-27F4E292-4C23-4245-B17D-F8F5C3F8A795

Q34221867-2D1AB103-3B32-480E-AE9A-DC5AA0168694

Q34221867-33715F3C-1DDC-4E17-9EA0-ECBEBE812DCA

P304

Q34221867-E55B12ED-D2D7-46A0-8095-80409759945E

P31

Q34221867-2544243F-2AD6-486C-92CC-BCEC61DC547E

P356

Q34221867-8E21A483-E3E2-4D38-BEBC-1400924CF395

P407

Q34221867-84B546A4-496B-40FC-B123-BD3013D43893

P433

Q34221867-14E786F8-79F4-409A-8D3D-E16176BDB3E8

P478

Q34221867-AE172429-9765-4996-A965-5551361CC2C8

P577

Q34221867-ED5892CC-42DE-4A3D-9D53-03403D88C003

P5875

Q34221867-73787AA8-B5C8-4AB4-9F1D-6E0CCCA3EDA3

P698

Q34221867-EC0103E3-99F4-4675-A4DB-1BE03C37B7CE

P932

Q34221867-A41C2C60-53DD-4217-8FF6-7AC5207133A7

P356

ONCOTARGET.2114

P1433

P1476

Tumor suppressor XAF1 induces ...... h in hepatocellular carcinoma.

@en

P2093

Dong Mei Shi

http://www.w3.org/2001/XMLSchema#string

Li Ming Zhu

http://www.w3.org/2001/XMLSchema#string

Min Min Qiao

http://www.w3.org/2001/XMLSchema#string

Ping Hu Sun

http://www.w3.org/2001/XMLSchema#string

Qiang Dai

http://www.w3.org/2001/XMLSchema#string

Shi Hu Jiang

http://www.w3.org/2001/XMLSchema#string

Shui Ping Tu

http://www.w3.org/2001/XMLSchema#string

Wei Yan Yao

http://www.w3.org/2001/XMLSchema#string

Xiao Jiao Cheng

http://www.w3.org/2001/XMLSchema#string

Yanfei Ding

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of XAF1 as an antagonist of XIAP anti-Caspase activity

Vascular endothelial growth factor is a secreted angiogenic mitogen

The biology of vascular endothelial growth factor

IAP proteins: blocking the road to death's door

Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis

Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines.

Molecular genetics of hepatocellular neoplasia.

Isorhapontigenin (ISO) inhibited cell transformation by inducing G0/G1 phase arrest via increasing MKP-1 mRNA Stability.

Origin and function of myofibroblasts in kidney fibrosis.

The IAP family: endogenous caspase inhibitors with multiple biological activities.

P304

5403-5415

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.2114

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263584267

http://www.w3.org/2001/XMLSchema#string

P698

24980821

http://www.w3.org/2001/XMLSchema#string

P932

4170645

http://www.w3.org/2001/XMLSchema#string